(Q51457954)

5 April 2018

title

Risk of sedation for upper GI endoscopy exacerbating subclinical hepatic encephalopathy in patients with cirrhosis. (English)

1 reference

5 April 2018

main subject

liver cirrhosis

0 references

hepatic encephalopathy

1 reference

0 references

N Assy

1

1 reference

5 April 2018

B G Rosser

series ordinal

2

1 reference

5 April 2018

G R Grahame

series ordinal

3

1 reference

5 April 2018

G Y Minuk

series ordinal

4

1 reference

5 April 2018

language of work or name

English

0 references

publication date

1 June 1999

1 reference

5 April 2018

Gastrointestinal Endoscopy

published in

1 reference

5 April 2018

volume

49

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

690-694

1 reference

5 April 2018

Latent portasystemic encephalopathy. I. Nature of cerebral functional defects and their effect on fitness to drive.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

The diagnosis and prevalence of subclinical hepatic encephalopathy in apparently healthy, ambulant, non-shunted patients with cirrhosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Propranolol in the prevention of first upper gastrointestinal tract hemorrhage in patients with cirrhosis of the liver and esophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Conscious sedation for gastroscopy: patient tolerance and cardiorespiratory parameters.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Sedation and analgesia for endoscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Automated gas chromatography for studies of midazolam pharmacokinetics.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

The pharmacokinetics of midazolam in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Sedation for upper gastrointestinal endoscopy: results of a nationwide survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Transection of the oesophagus for bleeding oesophageal varices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Trailmaking and number-connection tests in the assessment of mental state in portal systemic encephalopathy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Mechanisms of hypoxemia during panendoscopy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Validity of the Trail Making Test as an Indicator of Organic Brain Damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Psychomotor performance defects in cirrhotic patients without overt encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Physicians, elderly drivers, and dementia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Fitness to drive in patients with cirrhosis and portal-systemic shunting: a pilot study evaluating driving performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Subclinical hepatic encephalopathy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

Midazolam. A review of its pharmacological properties and therapeutic use.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

The use of the visual evoked potential (VEP) in delineating a state of subclinical encephalopathy. A comparison with the number connection test (NCT).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

The influence of age on trail making test performance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0016-5107%2899%2970283-X

10.1016/S0016-5107(99)70283-X

7 January 2021

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018